TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Revenue

TScan Therapeutics had revenue of $1.05M in the quarter ending September 30, 2024, a decrease of -73.01%. This brings the company's revenue in the last twelve months to $9.36M, down -44.71% year-over-year. In the year 2023, TScan Therapeutics had annual revenue of $21.05M with 55.52% growth.

• Revenue (ttm): $9.36M
• Revenue Growth: -44.71%
• P/S Ratio: 13.51
• Revenue / Employee: $60,792
• Employees: 154
• Market Cap: 133.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	21.05M	7.51M	55.52%
Dec 31, 2022	13.54M	3.39M	33.47%
Dec 31, 2021	10.14M	9.06M	834.65%
Dec 31, 2020	1.09M	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.